Evotec SE

Business Description

Evotec SE is a Hamburg-based drug discovery and development company founded in 1993, operating across the United States, Europe, and beyond. The company works to create treatments for a wide range of conditions, including cancer, diabetes, heart disease, kidney and liver disorders, and rare diseases, among others. It partners with leading universities, hospitals, and research centers worldwide ? such as Harvard, Yale, Johns Hopkins, and Mass General Brigham ? as well as major pharmaceutical companies and biotechnology firms. Evotec also collaborates with venture capital groups and patient advocacy organizations to bring new therapies from early research through to development.